David Wessels - Corporate Strategy and Valuation
David Wessels - Corporate Strategy and Valuation
David Wessels - Corporate Strategy and Valuation
Professor David Wessels 2011 The Wharton School of the University of Pennsylvania p PA 19104 3620 Locust Walk, Philadelphia
CompanyA
MarketCapitalization($billions) Enterprise Value ($billions)
10.0%
60
$ billions
40
CompanyB
MarketCapitalization($billions)
4.4%
20
27
Session Overview
A valuation model of two simple companies
Although profitability metrics such as EBITDA & Earnings Per Share (EPS) correlate with value, this is not always the case. Upfront investments must also be considered. considered
Year1 Aftertax operatingprofit NetInvestment Free cashflow 100.0 (50 0) (50.0) 50.0
Boston Scientific
NEW YORK, Oct 21 (Reuters) - Boston Scientific reported a smaller third-quarter net loss on Tuesday as increased sales of implantable defibrillators helped to offset charges g and a decline in sales of its drug-coated g stents. The company's adjusted profit of 18 cents per share topped Wall Street expectations by 2 cents, according to Reuters Estimates. Estimates Total net sales for the quarter fell to $1.98 billion from $2.05 billion, but that was in line with Wall Street expectations. "It was kind of an on-target quarter and right now with Boston Scientific, Scientific not falling below the range of expectations is a good thing," said Phillip Nalbone, an analyst with RBC Capital Markets. Source: Wall Street Journal
18
G = IR * ROIC
Company A: Company B: 5% = 50% * 10% 5% = 25% * 20%
Company B Reinvestment Rate (IR) Return on New Investment Growth in Profits 25% 20% 5%
In our simple example, cash flows grow forever at a constant rate. Therefore, we growth p perpetuity p y formula to value each company. p y can use the g
Value = Cash Flow 3 Cash Flow1 Cash Flow 2 + + + ......... (1 + WACC) ( ) ( (1 + WACC) )2 (1 ( + WACC) )3
Cashflow1 WACC g
via the growing perpetuity rormula
Value =
10
11
Source: https://www.mscibarra.com/products/indices/us/performance.jsp
Professor David Wessels The Wharton School of the University of Pennsylvania
12
GrowthStocks
10.0% 8.0% 6 0% 6.0% 4.0% 2.0% 0 0% 0.0% 1.0% 5.0% 11.0% 17.0% 23.0%
Value Stocks
13
For the value index, the median ROIC, averaged over three years, and excluding goodwill, is only 15 percent percent, compared with 35 percent for the growth index The correlation of M/Bs with ROIC in 2005 was 20 percent, percent versus 1 percent for growth rates.
14
A Change in Composition
15
16
17
CompanyA
MarketCapitalization($billions) Enterprise Value ($billions)
10.0%
60
$ billions
40
CompanyB
MarketCapitalization($billions)
4.4%
20
27
Net Debt (18.0) 3,866.0 39,333.0 3,324.0 407.6 7,738.0 (43 8) (43.8) 2,205.2
1
Enterprise Value 25,045.9 40,665.8 217,490.8 12,479.8 5,298.1 34,190.6 643 3 643.3 6,961.1 IndustryMean IndustryMedian StdDev/Mean Revenue 2.9 2.5 2.7 2.4 2.0 1.7 19 1.9 1.5 2.3 2.4 20.2% EBITDA 10.5 9.4 10.9 11.0 8.9 8.8 10 4 10.4 8.6 10.0 10.4 9.3% EBITA 11.1 10.2 12.5 13.0 9.9 11.0 10 8 10.8 10.0 11.2 11.0 10.1%
Company ReckittBenckiser Colgate Palmolive Procter&Gamble Clorox Church&Dwight KimberlyClark Wd40 EnergizerHoldings
Cap 25,063.9 36,799.8 178,157.8 9,155.8 4,890.4 26,452.6 687 1 687.1 4,755.9
Debtanddebtequivalents,netofcash
19
RB.,2.9x
6% 5% 4% 3% 2% 1% 0% 15% 17% 19% 21% 23% 25% 27% 29% CLX,2.4x KMB,1.7x CHD,2.0x PG,2.7x
CL,2.5x
ProjectedEBITA Margin
20
21
An Alternative Interpretation
Action Start with the key value driver formula.
From the definition of ROIC ROIC, Profit equals invested capital times ROIC.
Value = Capital
ROIC g WACC g
22
An Alternative Intepretation
Action Add and Subtract WACC in the numerator.
Value = Capital
23
2,289
PV(Future Growth)
95 3,604
95 3,604
25
PV(Future Growth)
USDmillions
26